Literature DB >> 16807676

A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene.

Gustavo J Lourenço, Cassio Cardoso-Filho, Neiva S L Gonçales, Julia Y Shinzato, Luis C Zeferino, Helvia Nascimento, Fernando F Costa, Maria S C Gurgel, Carmen S P Lima.   

Abstract

We investigated the influence of the polymorphism D104N of the COL18A1 gene, encoding endostatin, on the occurrence of sporadic breast cancer in 181 patients and 448 controls. The homozygous 104NN polymorphism was found in five patients but was absent in controls (2.8% vs 0.0%; P = 0.002). Individuals with this genotype had a significantly increased risk for disease. Our results suggest, for the first time, that the homozygous 104NN polymorphism, even at low frequency, constitutes an important inherited determinant of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807676     DOI: 10.1007/s10549-006-9259-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

1.  Genetic polymorphisms in COL18A1 influence the development of osteosarcoma.

Authors:  Zhihao Guo; Tianji Zhang; Juntao Wu; Hongwei Wang; Xiaotan Liu; Linqiang Tian
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Type III Collagen Directs Stromal Organization and Limits Metastasis in a Murine Model of Breast Cancer.

Authors:  Becky K Brisson; Elizabeth A Mauldin; Weiwei Lei; Laurie K Vogel; Ashley M Power; Albert Lo; Derek Dopkin; Chand Khanna; Rebecca G Wells; Ellen Puré; Susan W Volk
Journal:  Am J Pathol       Date:  2015-03-17       Impact factor: 4.307

3.  Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells.

Authors:  Clément Faye; Antonio Inforzato; Marine Bignon; Daniel J Hartmann; Laurent Muller; Lionel Ballut; Bjorn R Olsen; Anthony J Day; Sylvie Ricard-Blum
Journal:  Biochem J       Date:  2010-04-14       Impact factor: 3.857

4.  Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer.

Authors:  José Augusto Rinck-Junior; Cristiane Oliveira; Gustavo Jacob Lourenço; Regina Aparecida Martinho Sagarra; Sophie Françoise Mauricette Derchain; José Getulio Segalla; Carmen Silvia Passos Lima
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-05       Impact factor: 4.553

5.  Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.

Authors:  Hans Petter Eikesdal; Hikaru Sugimoto; Gabriel Birrane; Yohei Maeshima; Vesselina G Cooke; Mark Kieran; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

6.  Molecular interplay between endostatin, integrins, and heparan sulfate.

Authors:  Clément Faye; Christophe Moreau; Emilie Chautard; Reidunn Jetne; Naomi Fukai; Florence Ruggiero; Martin J Humphries; Bjorn R Olsen; Sylvie Ricard-Blum
Journal:  J Biol Chem       Date:  2009-06-05       Impact factor: 5.157

7.  The first draft of the endostatin interaction network.

Authors:  Clément Faye; Emilie Chautard; Bjorn R Olsen; Sylvie Ricard-Blum
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

8.  Genotype analysis of the human endostatin variant p.D104N in benign and malignant adrenocortical tumors.

Authors:  Beatriz Marinho de Paula Mariani; Ericka Barbosa Trarbach; Tamaya Castro Ribeiro; Maria Adelaide Albergaria Pereira; Berenice Bilharinho Mendonca; Maria Candida Barisson Villares Fragoso
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

9.  A 3' UTR SNP in COL18A1 is associated with susceptibility to HBV related hepatocellular carcinoma in Chinese: three independent case-control studies.

Authors:  Xiaopan Wu; Jia Wu; Zhenhui Xin; Huifen Wang; Xilin Zhu; Liping Pan; Zhuo Li; Hui Li; Ying Liu
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

10.  Endostatin gene variation and protein levels in breast cancer susceptibility and severity.

Authors:  Sabapathy P Balasubramanian; Simon S Cross; Jenny Globe; Angela Cox; Nicola J Brown; Malcolm W Reed
Journal:  BMC Cancer       Date:  2007-06-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.